This inventor holds 1 USPTO granted patent. Top assignee: Technoderma Medicines Pte Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Li Xing in Small Molecule Compounds
Introduction
Li Xing is an accomplished inventor based in Zhejiang, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of small molecule compounds. His work focuses on creating highly efficient and specific inhibitors for various kinases, which are crucial in the treatment of numerous diseases.
Latest Patents
Li Xing holds 1 patent for a small molecule compound. This invention is characterized by its unique structural formula and includes various forms such as stereoisomers, geometric isomers, and pharmaceutically acceptable salts. The small molecule compound serves as a highly efficient JAK kinase inhibitor, specifically targeting Tyk2 and JAK1, and can function as a dual inhibitor for both.
Career Highlights
Li Xing is currently associated with Technoderma Medicines Pte Ltd., where he continues to innovate in the field of pharmaceuticals. His expertise in small molecule compounds has positioned him as a key player in the development of new therapeutic agents.
Collaborations
Li Xing collaborates with talented individuals such as Xiang Pan and Yang Wang, who contribute to his research and development efforts. Their combined expertise enhances the potential for groundbreaking discoveries in the pharmaceutical industry.
Conclusion
Li Xing's work in small molecule compounds exemplifies the innovative spirit of modern medicinal chemistry. His contributions are paving the way for new treatments that could significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile